CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Balance, shares at Dec. 31, 2021		19,695,532
Balance, amount at Dec. 31, 2021	$ 2,867,660	$ 19,696	$ 6,321,428	$ (3,459,214)	$ (14,250)
Warrant valuation expense	437,375	$ 0	437,375	0	0
Issuance of common stock, shares		208,000
Issuance of common stock, amount	416,000	$ 208	415,792	0	0
Offering costs paid in connection with sale of common stock	(76,525)	$ 0	(76,525)	0	0
Common stock issued for convertible note, shares		56,592
Common stock issued for convertible note, amount	56,591	$ 56	56,535	0	0
Acquisition of machinery and trademarks, shares		2,000,000
Acquisition of machinery and trademarks, amount	4,000,000	$ 2,000	3,998,000
Conversion of accounts payable to common stock, shares		50,000
Conversion of accounts payable to common stock, amount	100,000	$ 50	99,950
Partner capital contribution to joint venture	52,000		52,000
Common shares issuance - IPO 2, shares		1,000,000
Common shares issuance - IPO 2, amount	6,000,000	$ 1,000	5,999,000
Offering costs	(531,188)		(531,188)
Boustead cashless warrant conversion, shares		54,926
Boustead cashless warrant conversion, amount	0	$ 55	(55)
Titan General Agency, Ltd. Debt repayment, shares		266,667
Titan General Agency, Ltd. Debt repayment, amount	1,182,681	$ 267	1,182,414
North Equities USA Ltd. Marketing services, shares		41,494
North Equities USA Ltd. Marketing services, amount	100,000	$ 41	99,959
Net loss/equity attributable to non-controlling interests	0	0	0	(6,963)	6,963
Net loss for the nine months ended September 30, 2022	(2,024,039)	$ 0	0	(2,024,039)	0
Balance, shares at Sep. 30, 2022		23,373,213
Balance, amount at Sep. 30, 2022	12,580,555	$ 23,373	18,054,685	(5,490,216)	(7,287)
Balance, shares at Jun. 30, 2022		19,960,124
Balance, amount at Jun. 30, 2022	2,726,535	$ 19,960	7,154,605	(4,432,197)	(15,833)
Issuance of common stock, shares		1,000,000
Issuance of common stock, amount	6,000,000	$ 1,000	5,999,000	0	0
Offering costs paid in connection with sale of common stock	(531,188)	$ 0	(531,188)	0	0
Acquisition of machinery and trademarks, shares		2,000,000
Acquisition of machinery and trademarks, amount	4,000,000	$ 2,000	3,998,000
Conversion of accounts payable to common stock, shares		50,000
Conversion of accounts payable to common stock, amount	100,000	$ 50	99,950	0	0
Partner capital contribution to joint venture	52,000		52,000
Boustead cashless warrant conversion, shares		54,928
Boustead cashless warrant conversion, amount	0	$ 55	(55)
Titan General Agency, Ltd. Debt repayment, amount	1,182,681	267	1,182,414
Net loss/equity attributable to non-controlling interests	0	0	0	(8,546)	8,546
Net loss for the nine months ended September 30, 2022	(1,049,473)	$ 0	0	(1,049,473)	0
Titan General Agency Ltd. Debt repayment, shares		266,667
North Equities marketing services, paid with shares, shares		41,494
North Equities marketing services, paid with shares, amount	100,000	$ 41	99,959
Balance, shares at Sep. 30, 2022		23,373,213
Balance, amount at Sep. 30, 2022	12,580,555	$ 23,373	18,054,685	(5,490,216)	(7,287)
Balance, shares at Dec. 31, 2022		23,436,505
Balance, amount at Dec. 31, 2022	7,560,199	$ 23,436	18,095,184	(10,463,048)	(95,373)
Issuance of common stock, shares		4,830,000
Issuance of common stock, amount	7,245,000	$ 4,830	7,240,170	0	0
Offering costs	(634,600)	0	(634,600)	0	0
Net loss/equity attributable to non-controlling interests	0	0	0	73,486	(73,486)
Net loss for the nine months ended September 30, 2022	(6,251,412)	$ 0	0	(6,251,412)	0
Shares issued for consulting services, shares		265,000
Shares issued for consulting services, amount	320,400	$ 265	320,135	0	0
Capitalized value of warrants	374,453	$ 0	374,453	0	0
Common stock issued for convertible notes, shares		394,621
Common stock issued for convertible notes, amount	146,940	$ 395	146,545	0	0
Record beneficial conversion feature discount on convertible notes.	21,486		21,486
Balance, shares at Sep. 30, 2023		28,926,126
Balance, amount at Sep. 30, 2023	8,782,466	$ 28,926	25,563,373	(16,640,974)	(168,859)
Balance, shares at Jun. 30, 2023		28,343,728
Balance, amount at Jun. 30, 2023	10,598,080	$ 28,343	25,118,062	(14,405,058)	(143,267)
Net loss/equity attributable to non-controlling interests	0	0	0	25,592	(25,592)
Net loss for the nine months ended September 30, 2022	(2,261,508)	$ 0	0	(2,261,508)	0
Shares issued for consulting services, shares		250,000
Shares issued for consulting services, amount	307,500	$ 250	307,250
Record beneficial conversion feature discount on convertible notes.	21,486		21,486
Common stock issued for Cambero convertible note, shares		332,398
Common stock issued for Cambero convertible note, amount	117,908	$ 333	117,575	0	0
Reversal of capital contribution related to joint venture	(1,000)	$ 0	(1,000)	0	0
Balance, shares at Sep. 30, 2023		28,926,126
Balance, amount at Sep. 30, 2023	$ 8,782,466	$ 28,926	$ 25,563,373	$ (16,640,974)	$ (168,859)